TMO
68
5
AON
47
-15
FTI
63
8
T
17
-13
HAL
61
10
SNA
48
2
NWSA
71
-6
MMM
49
-3
VTR
55
-8
ORLY
35
-5
PHM
40
-2
ETN
56
3
PNC
57
-4
AMGN
41
10
IR
52
-5
HUM
50
10
VRSN
39
-4
NWS
46
-6
PLD
40
8
EW
51
-2
TMO
68
5
AON
47
-15
FTI
63
8
T
17
-13
HAL
61
10
SNA
48
2
NWSA
71
-6
MMM
49
-3
VTR
55
-8
ORLY
35
-5
PHM
40
-2
ETN
56
3
PNC
57
-4
AMGN
41
10
IR
52
-5
HUM
50
10
VRSN
39
-4
NWS
46
-6
PLD
40
8
EW
51
-2
Financhill
Back

NovoCure Ltd. Vs. Perspective Therapeutics, Inc. Industry Stock Comparison

Sell
45

NVCR
NovoCure Ltd.

Last Price:
$13.11
Seasonality Move:
-7.29%
Sell
50

CATX
Perspective Therapeutics, Inc.

Last Price:
$2.8100
Seasonality Move:
28.22%
Sell
45
NovoCure Ltd. (NVCR) is a Sell

Is NovoCure Ltd. a Buy, Sell or Hold?

  • The current NovoCure Ltd. [NVCR] share price is $12.93. The Score for NVCR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Perspective Therapeutics, Inc. (CATX) is a Sell

Is Perspective Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Perspective Therapeutics, Inc. [CATX] share price is $2.7500. The Score for CATX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NVCR Stock Price Chart

What is NovoCure Ltd.'s stock price today?

  • The NovoCure Ltd. share price today is $12.93
    The current trend is moderately bullish and NVCR is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics, Inc.'s stock price today?

  • The Perspective Therapeutics, Inc. share price today is $2.7500
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.24 Buy
Relative Strength Index (14 RSI): 51.58 Buy
Chaikin Money Flow: -763015 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (12.06 - 13.4) Buy
Bollinger Bands (100): (11.72 - 13.56) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.08 Buy
Relative Strength Index (14 RSI): 54.44 Buy
Chaikin Money Flow: 363305 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.2768 - 2.7768) Buy
Bollinger Bands (100): (2.3877 - 3.7677) Sell

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.24 Sell
20-day SMA: 12.87 Buy
50-day SMA: 12.5 Buy
200-day SMA: 14.73 Sell
8-day EMA: 13.14 Sell
20-day EMA: 12.9 Buy
50-day EMA: 12.75 Buy
200-day EMA: 14.77 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.77 Sell
20-day SMA: 2.6 Buy
50-day SMA: 2.52 Buy
200-day SMA: 3.02 Sell
8-day EMA: 2.75 Buy
20-day EMA: 2.65 Buy
50-day EMA: 2.71 Buy
200-day EMA: 3.56 Sell

NovoCure Ltd. Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $0.40 per share.

Perspective Therapeutics, Inc. Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.17 per share.

NovoCure Ltd. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):